March 05, 2020 Zynerba hopes to crack fragile X at last The next few months will see data on the cannabinoid Zygel in fragile X syndrome, and a hit – or at least a near miss – will be necessary for more than just approval.
February 24, 2020 First fragile X test is approved, and Zynerba could benefit The fragile X pipeline is strewn with failures, and crunch time is approaching for Zynerba’s cannabinoid.
